[1] GELLATLY S L,HANCOCK R E.Pseudomonas aeruginosa: new insights into pathogenesis and host defenses[J].Pathogens And Disease,2013,67(3): 159.DOI:10.1111/2049-632X.12033.
[2] 钱超.多重耐药铜绿假单胞菌临床分布及耐药性观察[J].中国医药导报,2016,13(4): 122.
[3] 齐志丽,段美丽,李昂.铜绿假单胞菌耐药机制研究现状[J].山东医药,2014,54(4): 83-85.DOI:10.3969/j.issn.1002-266X.2014.04.03 l.
[4] 王莉,崔巍,徐海.肿瘤患者痰液中检出铜绿假单胞菌的耐药性分析[J].中华医院感染学杂志,2013,23(22): 5558.
[5] PARK S Y,PARK H J,MOON S M,et al.Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia[J].BMC Infect Dis,2012,12: 308.DOI: 10.1186/1471-2334-12-308.
[6] YAMAGISHI Y,HAGIHARA M,HIRAI J,et al.In vitro and in vivo pharmacodynamic of colistin and aztreonam alone and in combination against multidrug-resistant pseudomonas aeruginosa[J].Chemotherapy,2016,62(2): 109.DOI:10.1159/000449367.
[7] 马建永.临床肺部感染评分在急性呼吸窘迫综合症患者病情及预后评估中的价值[J].中华医院感染学杂志,2013,23(6): 1270.
[8] 魏建新, 杨青. 多重耐药铜绿假单胞菌不同药物治疗疗效的比较[J].中国现代药物应用,2015,18(9):119.DOl:10.14164/jcnkicn11-5581/r.2015.18.090.
[9] 廖光冲,龙训辉.哌拉西林他唑巴坦联合阿米卡星治疗ICU铜绿假单胞菌肺炎的疗效观察[J].世界最新医学信息文摘,2015,15(68): 86.DOI:10.3969/j.issn.1671-3141.2015.68.074.
[10] 张婧,孙恒彪,潘祖汉,等.1123株铜绿假单胞菌临床分布及耐药性分析[J].检验医学及临床,2015,12(20): 3011.DOI:10.3969/j.issn.1672-9455.2015.20.015.
[11] FUJITANI S,SUN H Y,YU A L,et al.Pneumonia due to Pseudomonas aeruginosa: part Ι: epidemiology,clinical diagnosis,and source[J].Chest,2011,139(4): 909-910.DOI:10.1378/chest.10-0166.
[12] 常洪美,张丕,柴建华,等.重症监护室住院患者多重耐药定植菌调查与临床分析[J].中国感染控制杂志,2013,12(6): 441.DOl:10.3969/j.issn.1671-9638.2013.06.012. |
